# FDA Approves Vizz (aceclidine) for Presbyopia

> fda · REPORTED · 2025-07-07

The FDA approved Vizz (aceclidine) from LENZ Therapeutics as a once-daily miotic eyedrop for the treatment of presbyopia, offering near-vision improvement without reading glasses. The approval adds a new entrant to the growing pharmacological presbyopia market.

About LENZ Therapeutics: LENZ Therapeutics is an ophthalmology company developing pharmacological treatments for age-related vision conditions, with Vizz being its lead presbyopia product targeting the large population of adults who rely on reading glasses.

- Company: LENZ Therapeutics
- Sector: therapeutics
- Primary source: https://insider.thefdagroup.com/p/fda-approval-showcase-early-2025

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.